Drug Design of Cyclin-Dependent Kinase 2 Inhibitor for Melanoma from Traditional Chinese Medicine

ASIA unversity > 資訊學院 > 生物資訊與醫學工程學系 > 期刊論文 > Item 310904400/87148

jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://asiair.asia.edu.tw/ir/handle/310904400/87148

题名:	Drug Design of Cyclin-Dependent Kinase 2 Inhibitor for Melanoma from Traditional Chinese Medicine
作者:	Hsin-Chieh, T;Tang, Hsin-Chieh;陳語謙*
贡献者:	生物與醫學資訊學系
日期:	2014-06
上传时间:	2014-12-30 03:19:28 (UTC+0)
摘要:	One has found an important cell cycle controller. This guard can decide the cell cycle toward proliferation or quiescence. Cyclin-dependent kinase 2 (CDK2) is a unique target among the CDK family in melanoma therapy. We attempted to find out TCM compounds from TCM Database@Taiwan that have the ability to inhibit the activity of CDK2 by systems biology. We selected Tetrahydropalmatine, Reserpiline, and (+)-Corydaline as the candidates by docking and screening results for further survey. We utilized support vector machine (SVM), multiple linear regression (MLR) models and Bayesian network for validation of predicted activity. By overall analysis of docking results, predicted activity, and molecular dynamics (MD) simulation, we could conclude that Tetrahydropalmatine, Reserpiline, and (+)-Corydaline had better binding affinity than the control. All of them had the ability to inhibit the activity of CDK2 and might have the opportunity to be applied in melanoma therapy.
關聯:	JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY;2014:798742.
显示于类别:	[生物資訊與醫學工程學系 ] 期刊論文

文件中的档案:

档案	大小	格式	浏览次数
index.html	0Kb	HTML	447	检视/开启

在ASIAIR中所有的数据项都受到原著作权保护.